EventHealthNovember 17, 2026

Isomorphic Labs raises $5B Series C for AI drug discovery

Read original source →techcrunch.com

The round was co-led by Greenoaks and Sequoia Capital, with new investor Andreessen Horowitz and continued backing from Alphabet; it follows a $2.1B Series B in May. Isomorphic reports "positive preclinical results" in oncology and immunology and has deals with Eli Lilly, Novartis, and Johnson & Johnson.

7 sources

More stories today

Open the live feed